top of page

Topic

Non-Muscle Invasive Bladder Cancer (NMIBC)

32 Podcasts • 3 Courses on BackTable

Hear how experienced physicians manage Non-Muscle Invasive Bladder Cancer (NMIBC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Gem-iDRS for BCG Unresponsive Bladder Cancer: A Deep Dive
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 320  •  31 Jul 2026

Gem-iDRS for BCG Unresponsive Bladder Cancer: A Deep Dive

Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non–muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology, Dr. Ruchi Talwar interviews Dr. Sarah Psutka to explore the emerging role of a novel intravesical device that delivers sustained gemcitabine therapy for patients refusing or ineligible for cystectomy. They highlight new FDA-approved treatment options, real-world workflow considerations, and the clinical potential for continuous intravesical chemotherapy in a crowded therapeutic landscape.

This podcast is supported by

Johnson & Johnson

More on Non-Muscle Invasive Bladder Cancer (NMIBC)

Loading recent podcasts…

Urology

Urology # 320

Jul 30, 2026

with Dr. Sarah Psutka, Dr. Ruchika Talwar

Gem-iDRS for BCG Unresponsive Bladder Cancer: A Deep Dive

Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non–muscle invasive bladder...

960+ listens

Tumor Board

Tumor Board # 67

Jun 17, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

40+ listens

Urology

Urology # 308

Jun 10, 2026

with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...

1,000+ listens

Industry

Industry # 101

Jun 8, 2026

with Dr. Ruchika Talwar, Anish Parikh

Keeping Up With Changes in Urologic Oncology & General Urology

Are academic medical conferences falling short when it comes to preparing clinicians for the unpredictable realities of...

310+ listens

Urology

Urology # 316

Jul 13, 2026

with Dr. Adam Gadzinski, Dr. Ruchika Talwar

Bladder Cancer in the Community: Meeting Patients Where They Are

As bladder cancer treatment options expand, so do the challenges of delivering them in real-world practice. On this...

870+ listens

Urology

Urology # 310

Jun 17, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

1,100+ listens

Tumor Board

Tumor Board # 65

Jun 10, 2026

with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...

220+ listens

Tumor Board

Tumor Board # 63

Jun 3, 2026

with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt

Launching Co-Managed APP/MD Clinics for Bladder Cancer

Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...

280+ listens

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page